SCHEMBL10280642

SCHEMBL10280642

C=C(C)Nc1cc(C)nn1-c1nc2ccccc2[nH]1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.70
KDM4E B2RXH2 5/20 0.70
MAPT P10636 12/20 0.67
KMT2A Q03164 8/20 0.67
MEN1 O00255 7/20 0.67
LMNA P02545 4/20 0.67
ATM Q13315 2/20 0.67
TSHR P16473 2/20 0.67
NPSR1 Q6W5P4 7/20 0.66
TDP1 Q9NUW8 7/20 0.66
SMN1; SMN2 Q16637 6/20 0.66
MAPK1 P28482 2/20 0.66
HTT P42858 6/20 0.65
HPGD P15428 3/20 0.65
CYP1A2 P05177 2/20 0.65
CYP3A4 P08684 2/20 0.65
CYP2C9 P11712 2/20 0.65
CYP2C19 P33261 2/20 0.65
POLB P06746 2/20 0.65
CYP2D6 P10635 1/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL880413 0.88 ALDH1A1 (0.77) ALDH1A1KDM4EMAPTKMT2AMEN1
SCHEMBL880478 0.81 ALDH1A1 (0.84) ALDH1A1KDM4EMAPTKMT2AMEN1
SCHEMBL13522300 0.81 ALDH1A1 (0.88) ALDH1A1KDM4EMAPTKMT2AMEN1
SCHEMBL880258 0.81 NPSR1 (0.92) ALDH1A1KDM4EMAPTKMT2AMEN1
SCHEMBL21295 0.80 KMT2A (0.70) ALDH1A1KDM4EMAPTKMT2AMEN1
SCHEMBL29668346 0.80 KMT2A (0.70) ALDH1A1KDM4EMAPTKMT2AMEN1
SCHEMBL880412 0.79 ALDH1A1 (0.84) ALDH1A1KDM4EMAPTKMT2AMEN1
SCHEMBL10280604 0.79 TDP1 (1.00) ALDH1A1KDM4EMAPTKMT2AMEN1
SCHEMBL880480 0.78 MAPT (1.00) ALDH1A1KDM4EMAPTKMT2AMEN1
SCHEMBL16387688 0.78 MAPT (0.62) ALDH1A1KDM4EMAPTKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2433634-A2 Compounds, compositions and methods of inhibiting a-synuclein toxicity The Whitehead Institute for Biomedical Research (US) 2012-03-28 EP disclosed